Lung Diseases Clinical Trials

38 recruiting

Lung Diseases Trials at a Glance

75 actively recruiting trials for lung diseases are listed on ClinicalTrialsFinder across 6 cities in 48 countries. The largest study group is Not Applicable with 23 trials, with the heaviest enrollment activity in Kansas City, Philadelphia, and Houston. Lead sponsors running lung diseases studies include Boehringer Ingelheim, Dalarna County Council, Sweden, and Eko Devices, Inc..

Browse lung diseases trials by phase

Treatments under study

About Lung Diseases Clinical Trials

Looking for clinical trials for Lung Diseases? There are currently 38 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Lung Diseases trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Lung Diseases clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 75 trials

Recruiting
Phase 3

Study of Treatment With Sacituzumab and Zimberelimab for Patients With Lung Cancer Confined to the Chest and Previously Operated on Who Were Not Disease-free.

Lung Diseases
Fundación GECP129 enrolled30 locationsNCT06431633
Recruiting
Phase 3

A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases

Interstitial Lung DiseasesSystemic Autoimmune Rheumatic Diseases Associated Interstitial Lung Diseases
Boehringer Ingelheim400 enrolled158 locationsNCT06806592
Recruiting
Phase 3

A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

Interstitial Lung DiseasesFamilial Pulmonary FibrosisInterstitial Lung Abnormalities
Boehringer Ingelheim80 enrolled56 locationsNCT07201922
Recruiting

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Interstitial Lung DiseasePulmonary HypertensionPulmonary Hypertension Due to Lung Diseases and Hypoxia
United Therapeutics900 enrolled62 locationsNCT06388421
Recruiting

Lung Ultrasound in Critically Ill Obstetrics and Gynecological Patients

Gynecologic CancerUltrasoundLung Diseases+1 more
Ain Shams University64 enrolled1 locationNCT06728709
Recruiting
Phase 2

A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

Cardiovascular DiseasesFibrosisLung Diseases+3 more
Pulmovant, Inc.20 enrolled1 locationNCT07333183
Recruiting
Phase 1Phase 2

A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors

Thoracic Neoplasms, Lung Diseases, Small Cell Lung Carcinoma
MediLink Therapeutics (Suzhou) Co., Ltd.118 enrolled4 locationsNCT07407933
Recruiting

Collagen Fingerprinting for Stratification of Pulmonary Hypertension (PH) Patients

Pulmonary Hypertension Due to Lung Diseases
Medical University of Graz80 enrolled1 locationNCT07498244
Recruiting
Not Applicable

Respiratory Muscles and Work of Breathing in Children

Lung DiseasesNeuromuscular DiseasesScoliosis+4 more
Assistance Publique - Hôpitaux de Paris550 enrolled1 locationNCT05051254
Recruiting
Not Applicable

NIVATS Versus IGAVATS: a Pilot Trial Addressing Biopsy Quality in Undetermined Interstitial Lung Diseases

Lung Diseases, Interstitial
University Hospital, Montpellier24 enrolled1 locationNCT05722340
Recruiting
Not Applicable

Comparison of Two Strategies of One-lung Ventilation in Patients Undergoing Carcinological Lung Resection Surgery.

Lung Diseases
University Hospital, Montpellier120 enrolled1 locationNCT05525312
Recruiting

Prophylaxis Guided by Cytomegalovirus-specific T Cell Immunity to Prevent Cytomegalovirus Disease in Lung Transplant Recipients

Lung Diseases
University of Miami100 enrolled1 locationNCT06494033
Recruiting
Not Applicable

Defining a Technique for the Use of Cryogenic Catheters for Biopsy and Ablation for the Diagnostic and Treatment of Pulmonary Lesions: An Ex-Vivo Human Lung Model Study.

Lung Diseases
Centre hospitalier de l'Université de Montréal (CHUM)200 enrolled1 locationNCT05948904
Recruiting

Deep Functional Phenotyping of the ALA Lung Health Cohort

Lung Diseases
Johns Hopkins University1,000 enrolled12 locationsNCT06177717
Recruiting
Phase 3

A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

Lung Diseases, Interstitial
GlaxoSmithKline440 enrolled131 locationsNCT06572384
Recruiting
Phase 2

H01 in Adults With Interstitial Lung Disease (The SOLIS Study)

Interstitial Lung DiseaseLung Diseases, InterstitialIdiopathic Pulmonary Fibrosis
National Institute of Environmental Health Sciences (NIEHS)37 enrolled1 locationNCT06325696
Recruiting
Phase 2Phase 3

Anlotinib Capsules in the Treatment for IPF/PF-ILDs

Interstitial Lung Diseases
First Affiliated Hospital of Wenzhou Medical University30 enrolled1 locationNCT05828953
Recruiting

Interstitial Lung Disease: A Study From Infancy to Elderly Including Relatives

Interstitial Lung Diseases
Institut National de la Santé Et de la Recherche Médicale, France3,000 enrolled1 locationNCT06036719
Recruiting
Phase 2

BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)

Lung DiseasesBronchiolitis Obliterans SyndromeChronic Graft Versus Host Disease+1 more
Dana-Farber Cancer Institute45 enrolled5 locationsNCT05922761
Recruiting

American Lung Association (ALA) Lung Health Cohort

Lung Diseases
Johns Hopkins University4,000 enrolled37 locationsNCT04543461